Andrew Yu

Andrew is a director with Monitor Deloitte’s China Life Science Practice. He has over 14 years of experience in management consulting. During the past 10 years, Andrew has been working with several multinational pharmaceutical and medical device companies operating in China. He owns a broad range of functional expertise from growth strategy to operation excellence.